AMGEN INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that AMGEN INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $25.42B | Feb 9, 2021 |
| FY2020 | Dec 31, 2019 | $23.36B | Feb 9, 2021 |
| FY2020 | Dec 31, 2018 | $23.75B | Feb 9, 2021 |
| FY2019 | Dec 31, 2017 | $22.85B | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | $22.99B | Feb 13, 2019 |
| FY2017 | Dec 31, 2015 | $21.66B | Feb 13, 2018 |
| FY2016 | Dec 31, 2014 | $20.06B | Feb 14, 2017 |
| FY2015 | Dec 31, 2013 | $18.68B | Feb 16, 2016 |
| FY2014 | Dec 31, 2012 | $17.27B | Feb 19, 2015 |
| FY2013 | Dec 31, 2011 | $15.58B | Feb 24, 2014 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $36.75B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $33.42B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $28.19B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $26.32B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $25.98B | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $25.42B | Feb 9, 2023 |
| FY2021 | Dec 31, 2019 | $23.36B | Feb 16, 2022 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $4.74B | Feb 9, 2021 |
| FY2020 | Sep 30, 2020 | $4.54B | Feb 9, 2021 |
| FY2020 | Jun 30, 2020 | $4.42B | Feb 9, 2021 |
| FY2020 | Mar 31, 2020 | $4.38B | Feb 9, 2021 |
| FY2020 | Dec 31, 2019 | $4.63B | Feb 9, 2021 |
| FY2020 | Sep 30, 2019 | $4.43B | Feb 9, 2021 |
| FY2020 | Jun 30, 2019 | $4.56B | Feb 9, 2021 |
| FY2020 | Mar 31, 2019 | $4.23B | Feb 9, 2021 |
| FY2019 | Dec 31, 2018 | $4.91B | Feb 12, 2020 |
| FY2019 | Sep 30, 2018 | $4.47B | Feb 12, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.71B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $4.09B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $6.72B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $6.55B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $5.89B | Feb 14, 2024 |
| FY2020 | Dec 31, 2020 | $1.62B | Feb 9, 2021 |
| FY2020 | Sep 30, 2020 | $2.02B | Feb 9, 2021 |
| FY2020 | Jun 30, 2020 | $1.80B | Feb 9, 2021 |
| FY2020 | Mar 31, 2020 | $1.83B | Feb 9, 2021 |
| FY2020 | Dec 31, 2019 | $1.70B | Feb 9, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.08B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $7.26B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $7.90B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $9.57B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $7.64B | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $9.14B | Feb 9, 2023 |
| FY2021 | Dec 31, 2019 | $9.67B | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $10.26B | Feb 9, 2021 |
| FY2019 | Dec 31, 2017 | $9.97B | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | $9.79B | Feb 13, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.05B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $7.10B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $6.18B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $5.41B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $5.37B | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $5.73B | Feb 9, 2023 |
| FY2021 | Dec 31, 2019 | $5.15B | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $5.33B | Feb 9, 2021 |
| FY2019 | Dec 31, 2017 | $4.87B | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | $5.06B | Feb 13, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.96B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $11.49B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $8.47B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $9.72B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $9.26B | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $10.50B | Feb 9, 2023 |
| FY2021 | Dec 31, 2019 | $9.15B | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $11.30B | Feb 9, 2021 |
| FY2019 | Dec 31, 2017 | $11.18B | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | $10.35B | Feb 13, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.86B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.10B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $1.11B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $936.00M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $880.00M | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $608.00M | Feb 9, 2023 |
| FY2021 | Dec 31, 2019 | $618.00M | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $738.00M | Feb 9, 2021 |
| FY2019 | Dec 31, 2017 | $664.00M | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | $738.00M | Feb 13, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $90.59B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $91.84B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $97.15B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $65.12B | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | $61.17B | Feb 9, 2023 |
| FY2021 | Dec 31, 2020 | $62.95B | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $59.71B | Feb 9, 2021 |
| FY2019 | Dec 31, 2018 | $66.42B | Feb 12, 2020 |
| FY2018 | Dec 31, 2017 | $79.95B | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | $77.63B | Feb 13, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.66B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $5.88B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $6.23B | Feb 13, 2026 |
| FY2025 | Dec 31, 2022 | $3.66B | Feb 13, 2026 |
| FY2024 | Dec 31, 2021 | $6.70B | Feb 14, 2025 |
| FY2023 | Dec 31, 2020 | $9.41B | Feb 14, 2024 |
| FY2022 | Dec 31, 2019 | $9.67B | Feb 9, 2023 |
| FY2021 | Dec 31, 2018 | $12.50B | Feb 16, 2022 |
| FY2020 | Dec 31, 2017 | $25.24B | Feb 9, 2021 |
| FY2019 | Dec 31, 2016 | $29.88B | Feb 12, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.68B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $18.64B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $18.63B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $15.53B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $14.89B | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $14.69B | Feb 9, 2023 |
| FY2021 | Dec 31, 2019 | $14.70B | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $14.70B | Feb 9, 2021 |
| FY2019 | Dec 31, 2017 | $14.76B | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | $14.76B | Feb 13, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($25.11B) | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | ($27.59B) | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | ($26.55B) | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | ($28.62B) | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | ($24.60B) | Feb 9, 2023 |
| FY2021 | Dec 31, 2020 | ($21.41B) | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | ($21.33B) | Feb 9, 2021 |
| FY2019 | Dec 31, 2018 | ($17.98B) | Feb 12, 2020 |
| FY2018 | Dec 31, 2017 | ($5.07B) | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | ($438.00M) | Feb 13, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.13B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $11.97B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $10.94B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $7.63B | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | $7.99B | Feb 9, 2023 |
| FY2021 | Dec 31, 2020 | $6.27B | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $6.04B | Feb 9, 2021 |
| FY2019 | Dec 31, 2018 | $6.95B | Feb 12, 2020 |
| FY2018 | Dec 31, 2017 | $3.80B | Feb 13, 2019 |
| FY2018 | Dec 31, 2016 | $3.24B | Feb 13, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $54.60B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $60.10B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $64.61B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $38.95B | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | $33.31B | Feb 9, 2023 |
| FY2021 | Dec 31, 2020 | $32.99B | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $29.90B | Feb 9, 2021 |
| FY2019 | Dec 31, 2018 | $33.93B | Feb 12, 2020 |
| FY2018 | Dec 31, 2017 | $35.34B | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | $34.60B | Feb 13, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 14 | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 7 | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | 12 | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | 12 | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | 10 | Feb 14, 2024 |
| FY2020 | Dec 31, 2020 | 2 | Feb 9, 2021 |
| FY2020 | Sep 30, 2020 | 3 | Feb 9, 2021 |
| FY2020 | Jun 30, 2020 | 3 | Feb 9, 2021 |
| FY2020 | Mar 31, 2020 | 3 | Feb 9, 2021 |
| FY2020 | Dec 31, 2019 | 2 | Feb 9, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 14 | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 7 | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | 12 | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | 12 | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | 10 | Feb 14, 2024 |
| FY2020 | Dec 31, 2020 | 2 | Feb 9, 2021 |
| FY2020 | Sep 30, 2020 | 3 | Feb 9, 2021 |
| FY2020 | Jun 30, 2020 | 3 | Feb 9, 2021 |
| FY2020 | Mar 31, 2020 | 3 | Feb 9, 2021 |
| FY2020 | Dec 31, 2019 | 2 | Feb 9, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 538.80M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 536.90M | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | 535.40M | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | 534.00M | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | 558.30M | Feb 9, 2023 |
| FY2021 | Dec 31, 2020 | 578.30M | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | 591.40M | Feb 9, 2021 |
| FY2019 | Dec 31, 2018 | 629.60M | Feb 12, 2020 |
| FY2018 | Dec 31, 2017 | 722.20M | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | 738.20M | Feb 13, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.12B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $4.83B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $4.56B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $4.20B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $4.01B | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $3.76B | Feb 9, 2023 |
| FY2021 | Dec 31, 2019 | $3.51B | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $3.51B | Feb 9, 2021 |
| FY2019 | Dec 31, 2017 | $3.37B | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | $3.00B | Feb 13, 2019 |